Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Cash from Operating Activities
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
Cash from Operating Activities
¥4.1B
|
CAGR 3-Years
91%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
12%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Operating Activities
¥2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Operating Activities
¥3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
108%
|
CAGR 10-Years
30%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Operating Activities
¥3.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Operating Activities
¥3.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Operating Activities
¥927.2m
|
CAGR 3-Years
38%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
4.1B
CNY
Based on the financial report for Dec 31, 2023, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Cash from Operating Activities amounts to 4.1B CNY.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
12%
Over the last year, the Cash from Operating Activities growth was -41%. The average annual Cash from Operating Activities growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been 91% over the past three years , -5% over the past five years , and 12% over the past ten years .